09-20-2019 | Nephropathy | EASD 2019 | News
Mixed results for PRIORITY diabetic nephropathy trial
The CKD273 proteomic biomarker panel can predict which people with type 2 diabetes will develop detectable diabetic nephropathy, but early intervention with spironolactone does not mitigate this risk, report the PRIORITY investigators.
UKPDS clinical trial slide set
09-30-2018 | UKPDS | At a glance | Article
What we learned from the UKPDS
The UKPDS has so far generated an astonishing 93 original research papers. medwireNews rounds them up.
Ask the expert: Hypertension and diabetes
Glucose monitor, heart, and stethoscope/© Chinnapong/stock.adobe.com, Kidneys/© Crystal light / stock.adobe.com, Luigi Gnudi, Diabetic kidney disease: A call to primary care/© hywards / stock.adobe.com, Slide 1, Slide 2, Slide 3, Slide 4, Slide 5, PowerPointIcon, Files/© adimas / stock.adobe.com, Cholesterol/© Alexandr Mitiuc/Fotolia, Ask the expert: Hypertension and diabetes - Why aren't we reaching targets?, Ask the expert: Hypertension and diabetes - When should I be intervening?